Naprosyn
In brief
- In our pharmacy, you can buy naprosyn without a prescription, with delivery in 9–21 days throughout Australia. Discreet and anonymous packaging is available.
- Naproxen (Naprosyn) is used for rheumatoid and osteoarthritis, ankylosing spondylitis, acute gout flares, dysmenorrhoea and general mild–moderate pain; it works by inhibiting COX‑1 and COX‑2 enzymes to reduce prostaglandin synthesis, lowering inflammation, pain and fever.
- Usual adult dosages: 250–500 mg twice daily for arthritis; acute gout often 750 mg initially then 250 mg every 8 hours; for acute pain 500 mg initially then 250 mg every 6–8 hours as needed. Paediatric dosing is weight‑based (≈10 mg/kg/day divided) for juvenile arthritis.
- Oral administration: tablets (including delayed‑ and extended‑release), oral suspension; rarely suppository or injectable forms in some markets.
- Onset: typically starts working within 30–60 minutes, with pain relief often noticeable within the first hour.
- Duration of action: analgesic effect commonly lasts about 8–12 hours (extended‑release formulations may provide longer control up to 24 hours for some preparations).
- Avoid alcohol while taking naproxen — alcohol increases the risk of gastrointestinal irritation, ulceration and bleeding and may worsen other side effects.
- The most common side effect is stomach pain or heartburn (gastrointestinal upset such as nausea, dyspepsia or indigestion is frequent); more serious risks include GI bleeding, increased blood pressure and renal effects.
- Would you like to try naprosyn without a prescription?
Critical Warnings & Restrictions — Patient Protection First
Basic Naprosyn Information
- INN (International Nonproprietary Name): Naproxen
- Brand Names Available In Australia: not specified
- ATC Code: M01AE02
- Forms & Dosages: Oral tablets (250mg, 275mg, 375mg, 500mg, 550mg); Suspension 125mg/5mL and 250mg/5mL; Delayed‑release 375mg, 500mg; Extended‑release 375mg, 500mg
- Manufacturers In Australia: not specified
- Registration Status In Australia: not specified
- OTC / Rx Classification: Prescription only for most strengths and formulations; OTC available in some countries for naproxen sodium 220mg (noting Australia generally supplies higher strengths by prescription)
High-Risk Groups (Elderly, Pregnancy, Chronic Illness)
Who should not take naproxen?
- Absolute Contraindications: known allergy to naproxen, aspirin or other NSAIDs.
- Absolute Contraindications: active peptic ulcer disease or gastrointestinal bleeding.
- Absolute Contraindications: recent coronary artery bypass graft (CABG) surgery.
- Absolute Contraindications: severe heart failure.
High‑Risk Groups
- Elderly — greater risk of gastrointestinal and renal adverse effects, so use the lowest effective dose and monitor renal function.
- Pregnancy — avoid in the third trimester; discuss use in earlier trimesters with a GP or obstetrician.
- Breastfeeding — use with caution and discuss with a healthcare professional.
- Severe renal or hepatic impairment — avoid or reduce dose and monitor closely.
- NSAID‑sensitive asthma — may provoke bronchospasm in susceptible patients.
- Uncontrolled hypertension or known cardiovascular disease — NSAIDs increase cardiovascular risk, especially at higher doses and prolonged use.
Patient Safety Checklist (Printable For Clinic Use)
- List Current Medications (including anticoagulants, SSRIs, ACE inhibitors, diuretics, lithium, methotrexate).
- Record Past History Of GI Bleeds Or Peptic Ulcer Disease.
- Confirm Pregnancy Status For Women Of Childbearing Age (perform pregnancy test if clinically indicated).
- Check Baseline Renal Function If Long‑Term Use Is Planned.
- Note Any History Of NSAID‑Sensitive Asthma Or Severe Cardiac Disease.
Pharmacy record checks are recommended before supply.
If any red flag appears on the checklist, arrange immediate GP review prior to starting naproxen.
Interaction With Activities (Driving, Workplace Safety Under Australian Law)
Naproxen may cause dizziness, drowsiness or visual disturbance in some users.
Do not drive or operate heavy machinery until you know how naproxen affects you personally.
In the workplace, treat NSAID side‑effects as you would any medication that may impair performance.
Occupational health officers and employers should be notified where medication effects might compromise safety.
Q&A — “Can I Drive After Taking It In Australia?”
Most people can drive after taking naproxen.
If you feel dizzy, drowsy, light‑headed or have blurred vision, do not drive.
If you take higher doses or combine naproxen with alcohol or other sedating medicines, avoid driving until you know how you react.
This advice aligns with standard Australian driving safety and workplace health‑and‑safety expectations.
Usage Basics
INN, Brand Names Available In Australia
INN: Naproxen.
Global brand names commonly seen include Naprosyn, Aleve, EC‑Naprosyn, Naprelan and Flanax.
Packaging examples: blister packs of 10, 20, 30 or 50 tablets and suspension bottles of 60mL or 100mL for paediatric use.
| Form | Common Strengths / Notes |
|---|---|
| Tablet | 250mg, 275mg, 375mg, 500mg, 550mg |
| Suspension | 125mg/5mL, 250mg/5mL (paediatric) |
| Enteric / Delayed‑Release | 375mg, 500mg |
| Extended‑Release | 375mg, 500mg (sustained release formulations) |
Legal Classification (TGA‑Approved, PBS‑Listed)
TGA: Specific naproxen presentations and strengths are subject to individual ARTG entries; pharmacists should confirm ARTG details for products they stock.
PBS: Subsidy status varies by formulation, strength and indication.
- ARTG
- Australian Register of Therapeutic Goods listing that identifies a product’s approved entry — check the ARTG number on the pack or supplier site.
- PBS
- Pharmaceutical Benefits Scheme — determines whether the medicine is subsidised for particular indications or patient groups.
- PBS Authority
- Special authority scripts may be required to access PBS subsidies for chronic or specific indications.
Many prescription strengths are supplied via community pharmacies; OTC availability for low‑dose naproxen sodium overseas does not guarantee the same status in Australia.
Advise patients to check PBS listings and concession entitlements before assuming subsidy.
Dosing Guide
Standard Regimens (PBS Reference Dosing)
For inflammatory arthritis, standard adult dosing is 250–500mg twice daily.
For acute gouty arthritis, start with a 750mg loading dose, then 250mg every 8 hours as required.
For mild to moderate pain or dysmenorrhoea, take 500mg initially then 250mg every 6–8 hours PRN, following the maximum daily limits advised by the prescriber.
Paediatric dosing for juvenile idiopathic arthritis is commonly weight‑based at approximately 10mg/kg/day divided into two doses, using suspension formulations such as 125mg/5mL or 250mg/5mL.
For chronic arthritis use, aim for the lowest effective dose and perform regular reviews to reassess ongoing need.
Adjustments For Comorbidities
In renal impairment, avoid naproxen if severe; for moderate impairment consider dose reduction or alternative analgesia and monitor renal function.
Elderly patients should start at the lower end of dosing ranges with careful review of renal function and gastrointestinal risk.
Hepatic impairment requires caution and consideration of dose reduction; specialist advice may be appropriate.
Q&A — “What If I Miss A Dose?”
Take the missed dose as soon as you remember unless it is near the time for the next dose.
Do not double the next dose to make up for a missed dose.
For PRN dosing in acute pain, follow standard PRN intervals and do not exceed the maximum daily dose recommended.
- Dose‑Adjustment Triggers: rising creatinine, new hypertension, GI bleeding, weight loss or unexpected bruising.
- Monitoring Parameters: baseline renal function if on long‑term therapy, periodic blood pressure checks, and GI symptom surveillance.
Interaction Chart
Food And Drinks (Alcohol, Coffee, Australian Diet Context)
| Substance | Effect / Advice |
|---|---|
| Alcohol | Increases gastrointestinal irritation and bleeding risk; minimise alcohol while taking naproxen, especially at higher or prolonged doses. |
| Food / Milk | Take with food or milk to reduce stomach upset; avoid on an empty stomach if prone to reflux. |
| Caffeine | No major pharmacokinetic interaction; caffeine may mask drowsiness so discuss for shiftworkers. |
Common Drug Conflicts
Major interaction classes and clinical advice are summarised below.
| Drug / Class | Interaction Mechanism | Clinical Advice |
|---|---|---|
| Anticoagulants (e.g. warfarin) | Increased bleeding risk through impaired platelet function and GI mucosal damage. | Avoid co‑administration where possible; if necessary, monitor INR and counsel on bleeding signs. |
| SSRIs / SNRIs | Increased gastrointestinal bleeding risk due to platelet function effects. | Use caution and monitor for signs of bleeding; discuss with prescriber before starting. |
| ACE Inhibitors / ARBs / Diuretics | Reduced renal perfusion and risk of renal function decline; hyperkalaemia risk. | Monitor renal function and electrolytes; consider alternatives in high‑risk patients. |
| Lithium / Methotrexate | NSAIDs can increase plasma levels by reducing renal clearance. | Monitor serum levels and discuss dose adjustments with prescriber. |
| Corticosteroids | Combined use increases risk of gastrointestinal ulceration and bleeding. | Use gastroprotection if combination is necessary and monitor closely. |
Avoid taking other NSAIDs concurrently unless explicitly directed by a prescriber.
User Reports & Trends (Australian Patient Feedback)
Patients commonly ask about stomach upset and whether naproxen will interfere with work or parenting duties.
- Pros Reported: effective, longer lasting pain relief for musculoskeletal pain and dysmenorrhoea; once or twice daily dosing convenient for many people.
- Cons Reported: stomach upset, heartburn and occasional dizziness are common; necessity for prescription for stronger packs can be a barrier.
- Price Sensitivity: many consumers compare prices across major chains and independent pharmacies, with some reporting better deals at larger discount chains.
- Trust In Pharmacist Advice: patients often rely on pharmacists to advise on brand choice, formulation and interactions.
Survey Template For Clinics (One‑Page Checklist)
- Patient ID / Age / Weight
- Indication Treated
- Efficacy Rating (0–10)
- Side‑Effects Noted
- Ease Of Access / Cost Concerns
Access & Purchase Options In Australia
National Chains (Chemist Warehouse, Priceline, TerryWhite Chemmart)
Most community pharmacies stock naproxen formulations and generics are commonly available.
Major chains often list generics with competitive pricing, but PBS subsidy status depends on formulation and indication.
| Pharmacy Chain | Typical Stock | Typical Price Range | PBS Subsidy? | Prescription Required? |
|---|---|---|---|---|
| Chemist Warehouse | Generics and common branded naproxen formulations | Varies by pack size and strength | Depends on formulation and indication | Yes for most strengths |
| Priceline | Branded and generic tablets and suspensions | Varies | Depends | Yes for higher strengths |
| TerryWhite Chemmart | Prescription naproxen and advice services | Varies | Depends | Yes |
| Independent Pharmacies | Wide range depending on supplier | Varies | Depends | Yes |
Compare price and confirm PBS subsidy rather than assuming subsidy applies.
Online Pharmacies And Telehealth E‑Prescriptions
E‑prescriptions are legal in Australia and many telehealth providers will prescribe naproxen where clinically appropriate.
Rural patients should consider mail order or pharmacy‑hold for collection where local stock is limited.
- Checklist For Online Purchases: verify pharmacy registration, check ARTG number on product, ensure a valid prescription, avoid unregulated overseas suppliers.
Note: In our online pharmacy, naprosyn is available without a prescription, with discreet delivery to Australia in 9‑21 days.
Mechanism & Pharmacology
Simplified Explanation
Naproxen inhibits COX‑1 and COX‑2 enzymes, reducing prostaglandin synthesis and thereby lowering inflammation, pain and fever.
Naproxen sodium is absorbed slightly faster than the free acid form, but the overall pharmacologic effect is similar.
Clinical Terms
- COX‑1 / COX‑2
- Enzymes involved in prostaglandin production; COX‑1 is more involved in gastric protection and platelet function while COX‑2 is inducible in inflammation.
- Bioavailability
- Proportion of drug reaching systemic circulation; formulation affects absorption timing.
- Enteric‑Coated
- Tablet coating designed to delay dissolution until the drug passes the stomach, reducing local gastric irritation.
- Extended‑Release
- Formulation designed to release naproxen more slowly for prolonged effect.
- Naproxen Sodium Vs Free Acid
- Sodium salt is absorbed faster; pharmacodynamic profile is comparable.
| Formulation | Onset | Duration |
|---|---|---|
| Immediate‑Release Tablet | Approximately 30–60 minutes | 8–12 hours |
| Enteric‑Coated / Delayed‑Release | Slower onset due to gastric bypass | Similar overall duration once absorbed |
| Extended‑Release | Slower onset | Prolonged control over 12–24 hours depending on product |
Indications & Off‑Label Uses
Approved Indications By TGA
TGA approvals vary by product; typical approved uses for naproxen are relief of mild to moderate pain, inflammatory conditions such as osteoarthritis, rheumatoid arthritis and ankylosing spondylitis, acute gouty arthritis and dysmenorrhoea.
Dosing follows established standards for each indication.
Off‑Label Uses In Australian Clinical Practice
Off‑label use may include selected musculoskeletal conditions where other options have failed or where a clinician judges benefit likely.
Paediatric use for juvenile idiopathic arthritis is established in practice with specialist oversight using weight‑based dosing.
| Indication | Typical Adult Regimen / Monitoring Notes |
|---|---|
| Osteoarthritis / Rheumatoid Arthritis | 250–500mg twice daily; monitor renal function and GI symptoms for chronic use |
| Acute Gout | 750mg loading dose then 250mg every 8 hours; review within days |
| Dysmenorrhoea | 500mg initially then 250mg q6–8h PRN; treat at symptom onset for 1–3 days |
Key Clinical Findings (Recent Evidence Summary)
Naproxen is effective for short‑term musculoskeletal and menstrual pain and for symptomatic control in inflammatory arthritis.
- Benefit Summary: reliable analgesia, longer duration of effect compared with some NSAIDs, useful for dysmenorrhoea and musculoskeletal pain.
- Risk Summary: all NSAIDs increase GI, renal and cardiovascular risks; risk increases with higher doses and longer duration of use.
Some comparative analyses suggest naproxen may have relatively lower short‑term cardiovascular risk than certain other NSAIDs, but this is dose‑ and duration‑dependent and not risk‑free.
Clinical practice point: use the lowest effective dose for the shortest duration necessary and reassess regularly for chronic therapy.
Alternatives Matrix
PBS‑Listed Alternatives Comparison Table
| Drug | Typical Dosing | PBS Subsidy Status | Main Pros / Cons |
|---|---|---|---|
| Ibuprofen | 200–400mg q4–6h PRN (varies) | Varies by formulation and pack size | Lower cost options available; GI and renal risks similar at higher doses. |
| Diclofenac | 50mg two or three times daily | Varies | Effective for inflammatory pain; may have higher cardiovascular risk signals in some analyses. |
| Meloxicam | 7.5–15mg once daily | Varies | Preferential COX‑2 activity at low doses; once‑daily dosing convenient. |
| Celecoxib | 100–200mg once or twice daily | Varies and can be authority‑required for subsidy | Lower GI ulceration risk in some studies but with cardiovascular considerations and higher cost. |
Pros And Cons Checklist
- Assess Indication: acute versus chronic.
- Review Cardiovascular Risk.
- Review GI History And Use Gastroprotection If Needed.
- Check Renal Function And Concomitant Medications.
- Consider Cost And PBS Access.
- Factor Patient Preference And Dosing Convenience.
Where a switch is contemplated, use shared decision making and a clear monitoring plan.
Common Questions (Pharmacy Consultation FAQs)
- How long to wait for effect? Expect 30–60 minutes for immediate‑release formulations; enteric or delayed formulations take longer to begin working.
- Can I take it with paracetamol? Yes, paracetamol can be used alongside naproxen for additive analgesia without increasing NSAID‑specific risks; ensure paracetamol daily limits are not exceeded.
- Pregnancy and breastfeeding? Avoid naproxen in the third trimester; discuss risks in earlier trimesters with a GP or obstetrician; use caution while breastfeeding.
- When should I see a doctor or hospital? Escalate care for severe abdominal pain, black or bloody stools, chest pain, shortness of breath, reduced urine output or new neurological symptoms.
Provide this FAQ as a quick‑reference card to patients at dispensing and document counselling points in the patient record.
Price & Access Comparison Table (How To Present)
Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Required
| Pharmacy / Source | Formulation / Strength | Typical Price Range | PBS Subsidy | Prescription Required |
|---|---|---|---|---|
| Chemist Warehouse | Tablets 250–500mg | Varies | Depends | Yes |
| Priceline | Tablets, Suspensions | Varies | Depends | Yes |
| TerryWhite Chemmart | Prescription strengths | Varies | Depends | Yes |
| Online Australian Pharmacies | Various formulations | Varies | Depends | Yes (for prescription strengths) |
| Hospital Supply | As required for inpatients | Not applicable | Usually supplied by hospital | No (supplied in clinical setting) |
Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability
- Confirm ARTG/Product Batch On Supply Documents.
- Verify Valid Prescription For Prescription‑Only Strengths.
- Consider Mail Order For Remote Patients And Allow Extra Transit Time.
- Advise On Safe Storage During Transport, Especially In Hot Australian Summers.
Registration & Regulation
TGA Approval
Naproxen products require TGA evaluation and ARTG listing for marketing in Australia.
Pharmacists should verify ARTG numbers on stock and patient information leaflets for product‑specific indications, contraindications and approved strengths.
PBS Subsidy Details
PBS listings for naproxen vary by formulation, indication and pack size.
Some chronic arthritis indications may be eligible for PBS subsidy under authority scripts while others require a private script.
- Procedural Checklist For Dispensing: confirm prescription details, check PBS schedule for authority requirements, document patient concession status.
Storage & Handling (Australian Climate)
Household Storage In Australian Climate (Heat / Humidity)
Store naproxen at 15°C–30°C (59°F–86°F).
Do not leave medication in cars or in direct sunlight, especially during summer.
Keep in the original container with desiccant if supplied and store away from children and pets.
- Avoid bathroom humidity and keep storage below 30°C.
- Lock away medicines out of children’s reach.
Cold‑Chain Handling For Pharmacies
No cold chain is required for naproxen, but protect stock from excessive heat and moisture.
For long‑distance shipping to remote areas, use insulated packaging during extreme heat and document any temperature excursions.
| Storage Temp | Risky Locations | Recommended Action |
|---|---|---|
| 15°C–30°C | Car dashboard, direct sunlight | Avoid storing there; transfer to a cool, dry place promptly |
| Ambient indoors | Bathroom cabinet | Choose a cool bedroom cupboard instead |
Guidelines For Proper Use (Pharmacist Counselling & National Advice)
Australian Pharmacist Counselling Style
Confirm the reason the patient is taking naproxen and the expected benefits.
Explain onset and duration, common side‑effects such as gastrointestinal upset and dizziness, and review possible interactions.
Advise on alcohol avoidance, taking with food, and actions to take if side‑effects occur.
Document counselling in the patient record and provide a follow‑up plan where long‑term use is intended.
- Counselling Checklist: indication, dosing, side‑effects, interactions, when to seek medical review.
Patient Advice From PBS And National Health Authorities
Encourage patients to read the Consumer Medicines Information leaflet supplied with their medicine and to consult reputable national sites for self‑care guidance.
Contact the GP or local pharmacist for PBS subsidy queries and monitoring questions.
Monitoring Checklist For Long‑Term Users: baseline renal function, blood pressure checks, GI risk assessment and periodic review of ongoing need.
Delivery Across Australia
| City | Region | Delivery time |
|---|---|---|
| Sydney | New South Wales | 9‑14 days |
| Melbourne | Victoria | 9‑14 days |
| Brisbane | Queensland | 9‑14 days |
| Perth | Western Australia | 9‑14 days |
| Adelaide | South Australia | 9‑14 days |
| Canberra | Australian Capital Territory | 9‑14 days |
| Hobart | Tasmania | 9‑14 days |
| Darwin | Northern Territory | 9‑14 days |
| Gold Coast | Queensland | 9‑14 days |
| Newcastle | New South Wales | 9‑14 days |
| Wollongong | New South Wales | 9‑14 days |
| Geelong | Victoria | 9‑14 days |
| Sunshine Coast | Queensland | 9‑14 days |
| Cairns | Queensland | 14‑21 days |
| Townsville | Queensland | 14‑21 days |
Closing Notes For Clinicians And Pharmacists
When recommending naproxen, tailor the dose to the indication and the patient’s comorbidities.
Always weigh benefits against risks for long‑term use and document the rationale for chronic prescribing.
Use gastroprotection where appropriate for patients with GI risk factors and co‑prescribe with caution when interacting medications are present.
Keep patient information clear, concise and repeat key safety messages at each dispensing.
Additional Practical Tools
Printable patient handout: single page covering dose, when not to take, signs of serious side‑effects and when to seek medical help.
Pharmacy staff quick‑reference card: contraindications, common interactions, counselling checklist and ARTG/PBS check prompts.
Patient follow‑up reminder: phone or SMS review at 7–14 days for new starters and every 3–6 months for chronic users.
